NCT01339676

Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)

Colecalciferol as an Add-on Treatment to Subcutaneously Administered Interferon-beta-1b for Treatment of MS

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: University of Turku · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-centre, double blind, randomised, placebo controlled, parallel group, phase 4 pilot study investigating colecalciferol (vitamin D3) as an add-on treatment to subcutaneously administered interferon-beta-1b in relapsing-remitting multiple sclerosis patients.

Conditions

• Multiple Sclerosis

Interventions

Type	Name	Description
DRUG	Colecalciferol	Once weekly treatment with peroral colecalciferol capsules (Dekristol®, Swiss-Caps, Switzerland) containing 20 mg of colecalciferol corresponding to 20000 IU or 0.5 mg of vitamin D
DRUG	Placebo capsules	Identically appearing once weekly peroral placebo capsules

Timeline

• Start date: 2008-03-01
• Primary completion: 2011-05-01
• Completion: 2011-06-01
• First posted: 2011-04-21
• Last updated: 2011-05-19

Locations

1 site across 1 country: Finland